Results 181 to 190 of about 24,901 (225)
Some of the next articles are maybe not open access.

[Psychostimulants].

Revue medicale de Liege, 2008
Over the last twenty years, cocaine, amphetamines and MDMA (ecstasy) have found new categories of users, seeking for their stimulating effects. These substances may lead to real dependence and may cause serious somatic and psychiatric damage. In this perspective, we reviewed the available literature concerning problematic psychoactive drug use in ...
E, Pinto, W, Pitchot, M, Ansseau
  +6 more sources

Psychostimulants

2020
A current survey and synthesis of the most important findings in our understanding of the neurobiological mechanisms of addiction are detailed in our Neurobiology of Addiction series, each volume addressing a specific area of addiction. Psychostimulants, Volume 2 in the series, explores the molecular and cellular systems in the brain responsible for ...
Koob, Georges F.   +3 more
openaire   +3 more sources

Psychostimulants for depression

Cochrane Database of Systematic Reviews, 2007
Depression is common, disabling, costly and under-treated. There are problems in the current first-line drug treatment, antidepressants, for moderate or severe depression. There is a body of research that has evaluated the effect of psychostimulants (PS) in the treatment of depression.
M, Candy   +4 more
openaire   +2 more sources

Psychostimulants in Psychiatry

The Canadian Journal of Psychiatry, 1990
The use of the psychostimulants in psychiatry is reviewed. A brief historical perspective on dextroamphetamine is presented, and a brief review of the psychopharmacology of dextroamphetamine, methylphenidate and magnesium pemoline is given. The literature on the use of stimulants in the treatment of resistant depression, apathetic geriatric patients ...
openaire   +2 more sources

The Pharmacokinetics and Pharmacogenomics of Psychostimulants

Child and Adolescent Psychiatric Clinics of North America, 2022
The psychostimulants-amphetamine and methylphenidate-have been in clinical use for well more than 60 years. In general, both stimulants are rapidly absorbed with relatively poor bioavailability and short half-lives. The pharmacokinetics of both stimulants are generally linear and dose proportional although substantial interindividual variability in ...
John S, Markowitz, Philip W, Melchert
openaire   +2 more sources

Psychostimulant use and the brain

Addiction, 2019
AbstractPsychostimulant users are typically young adults. We have conducted a narrative review of neuropsychiatric harms associated with the psychostimulants methamphetamine/amphetamine, cocaine and 3,4‐methylenedioxymethamphetamine (MDMA), focusing on epidemiological factors, common clinical presentations, underlying causal mechanisms and treatment ...
Julia M. Lappin, Grant E. Sara
openaire   +2 more sources

Hyperthermia in Psychostimulant Overdose

Annals of Emergency Medicine, 1994
Psychostimulant drugs such as amphetamines, amphetamine derivatives, and cocaine produce a variety of potentially lethal effects, and an understanding of these toxic effects is important for emergency physicians. While some effects of psychostimulant poisonings such as cardiovascular compromise and seizures have been discussed extensively, other ...
C W, Callaway, R F, Clark
openaire   +2 more sources

Drug interactions with psychostimulants

International Clinical Psychopharmacology, 1999
The psychostimulants methylphenidate, dextroamphetamine, and pemoline are among the most common medications used in child and adolescent psychiatry. Often, these agents are used in combination with other medications. This review summarizes reported drug interactions and assesses both causality and clinical significance.
J S, Markowitz   +2 more
openaire   +2 more sources

Use of Psychostimulants for the Elderly

Psychiatric Services, 1990
As the number of people over age 65 continues to grow, a clear understanding of the usefulness and limitations of psychostimulants in treating elderly persons becomes more important. The authors review the limited literature and discuss the use of psychostimulants for treating "senility," including their effects on cognition, amotivational syndromes ...
W H, Roccaforte, W J, Burke
openaire   +2 more sources

Psychostimulants

2021
Ion-George Anghelescu, Eike Ahlers
openaire   +2 more sources

Home - About - Disclaimer - Privacy